Weekly Policy Update: New Economic Forecast Indicates Increase in Expected Revenue Above the TABOR Cap

The Colorado Legislative Council released their updated budget and economic forecast this week, which showed a strong economy in the state of Colorado, an increase in expected revenue, and high wage g...

Learn More

Weekly Policy Update: CBSA Submits Comment Letter to Senate Finance Committee’s Health Task Force Urging Repeal of the Medical Device Excise Tax

Last month, leaders of the Senate Finance Committee announced the formation of several bipartisan task forces to examine 42 temporary tax provisions that expired or will expire between December 31, 20...

Learn More

CutisPharma Announces Acquisition of Silvergate Pharmaceuticals, Name Change to Azurity Pharmaceuticals

WOBURN, Mass. (Jun. 12, 2019) – CutisPharma, Inc. announced today its acquisition of Silvergate Pharmaceuticals, Inc. and the unveiling of its new corporate brand for the unified company: Azurity Phar...

Learn More

Weekly Policy Update: CBSA Attends the 2019 BIO International Convention

Last week CBSA President and CEO Jennifer Jones Paton and Vice President Emily Roberts attended the 2019 BIO International Convention in Philadelphia. The event brings together over 16,000 attendees f...

Learn More

Improving the Reimbursement Landscape for Medical Technology Innovators

CBSA continues to work with Congress and federal policymakers to improve the reimbursement landscape for medical technology innovators. Even when groundbreaking and innovative technologies meet FDA’s...

Learn More

CMS Rolls Back Harmful Proposals in Medicare Part D

Last Thursday CMS finalized a rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses, which included a number of significant changes to the proposed r...

Learn More

Weekly Policy Update: CMS Proposed Rule is a Step Forward for the Coverage of Breakthrough Technologies

In late April, the Centers for Medicare and Medicaid Services (CMS) publicly released its FY 2020 Inpatient Prospective Payment System (IPPS) Proposed Rule. The rule is a critical step forward for cov...

Learn More

Weekly Policy Update: The Final Tally - 2019 Legislative Session Comes to a Close

CBSA has worked hard this session to advocate on behalf of the industry. We’ve worked with our members and partners to advance proposals that promote patient safety, protect patient access, and enhanc...

Learn More

Weekly Policy Update: One Week Left - What Will Make It Across the Finish Line

With just over a week left in the 2019 legislative session, there are hundreds of bills left to debate and Democrats are scrambling to get their remaining priorities across the finish line. Here are s...

Learn More

CBSA Opposes Drug Importation and Continues to Advocate for Safe Policy to Reduce Patient Costs

Last week CBSA testified in the House Health and Insurance Committee in opposition to Senate Bill 005 - Import Prescription Drugs From Canada, which would require the Department of Health Care Policy...

Learn More